Welcome to our dedicated page for Acacia Resh SEC filings (Ticker: ACTG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Struggling to track royalty wins, litigation updates, and new acquisition details buried in Acacia Research’s SEC paperwork? Each 10-K intertwines dense patent law with multi-sector financials, while Form 4 insider trades can shift sentiment overnight. Finding the datapoints that predict cash-flow swings is time-consuming.
Stock Titan solves this problem. Our AI reads every Acacia Research SEC filing the instant it posts to EDGAR—whether it is a 10-Q quarterly earnings report, an 8-K material event, or a proxy statement on executive compensation. We surface plain-English summaries, red-line changes, and context so you can understand Acacia Research SEC filings explained simply.
Use the platform to:
- Receive real-time alerts on Acacia Research Form 4 insider transactions and monitor patterns in executive stock sales or option exercises.
- Compare segment margins across industrial, energy, and IP licensing operations with our AI-tagged tables inside every Acacia Research quarterly earnings report 10-Q filing.
- Spot settlement proceeds or royalty step-ups reported in the Acacia Research annual report 10-K simplified view.
- Quickly interpret unexpected announcements in the Acacia Research 8-K material events explained feed.
Whether you type "understanding Acacia Research SEC documents with AI" or "Acacia Research earnings report filing analysis", this page delivers. Analysts, portfolio managers, and private investors rely on our comprehensive coverage of Acacia Research insider trading Form 4 transactions, governance updates, and acquisition disclosures—updated the moment they hit the SEC. Spend less time parsing legal language and more time making informed decisions.
Acacia Research (ACTG) reported Q3 results showing higher revenue and narrower losses while integrating recent acquisitions across energy, industrial, and manufacturing operations.
Total revenue was $59.4 million, up from $23.3 million a year ago, led by manufacturing ($30.8 million) from the Deflecto business and stronger intellectual property licensing ($7.8 million, driven by paid-up licenses). Energy contributed $14.2 million and industrial $6.7 million. Operating loss improved to $6.4 million from $10.3 million, and net loss attributable to Acacia narrowed to $2.7 million, or $0.03 per share, from $14.0 million, or $0.14 per share.
For the nine months, revenue reached $235.1 million versus $73.5 million, with operating income of $19.5 million and net income of $18.3 million. Cash and cash equivalents were $301.8 million as of September 30, 2025. Benchmark’s revolving credit facility balance was $58.5 million and the Deflecto facility was $35.5 million. Shares outstanding were 96,460,378 as of September 30, 2025.
Acacia Research Corporation furnished a press release announcing its financial results for the quarter ended September 30, 2025. The release was provided under Item 2.02 and is attached as Exhibit 99.1. The company notes this information is being furnished and is not deemed “filed” under Section 18 of the Exchange Act, and it will not be incorporated by reference into Securities Act filings unless specifically referenced.
Exhibits include: 99.1 (Press Release dated November 5, 2025) and 104 (Cover Page Interactive Data File).
Gavin T. Molinelli, a director of Acacia Research Corp (ACTG), received 9,231 shares of the company's common stock on 09/30/2025 as payment in lieu of cash for director fees for Q3 2025. The shares were issued at a price of $3.25 per share. After the grant, Mr. Molinelli beneficially owned 160,218 shares of Acacia Research Corp.
The Form 4 was signed by Mr. Molinelli on 10/01/2025 and reports a routine, non-derivative acquisition of equity tied to director compensation. The filing shows direct ownership and does not report any derivative transactions.
Zambito Michael SIKORYAK, identified on the filing as the issuer's Chief Financial Officer, reported a purchase of 7,700 shares of Acacia Research Corporation (ACTG) on 08/11/2025. The transaction was coded P for a purchase and was executed at a weighted average price of $3.2658, with the filing noting component trades priced between $3.25 and $3.32. Following the transaction the reporting person beneficially owned 7,700 shares in a direct capacity.
The Form 4 was signed by an attorney-in-fact, Jennifer Graff, on 08/12/2025. No derivative transactions or other securities classes are reported on this filing, and no amendments or additional material items are included.
Michelle Felman, identified as a director of Acacia Research Corporation (ACTG), reported two gift transactions of company common stock dated 08/11/2025. The filing states she gifted 11,560 shares and 11,561 shares to an irrevocable trust established for the benefit of her son, and that each gift was for no consideration.
The Form 4 shows the transactions coded as gifts and reports post-transaction direct beneficial ownership figures of 43,733 shares and 32,172 shares respectively as listed on the form. The filing is signed by an attorney-in-fact.
FAQ
What is the current stock price of Acacia Resh (ACTG)?
What is the market cap of Acacia Resh (ACTG)?
